Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial

Linagliptin Suppresses Electrical and Structural Remodeling in the Isoproterenol Induced Myocardial Injury Model

(2019) Naruya Ishizue et al.   International Heart Journal

The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors

(2018) Angelo Avogaro et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Gastrointestinal Motility Problems in Critically Ill Patients

(2018) Christine Frazer et al.   Critical Care Nursing Clinics of North America

DPP4 Inhibition Ameliorates Cardiac Function by Blocking the Cleavage of HMGB1 in Diabetic Mice After Myocardial Infarction

(2017) Akihiko Sato et al.   International Heart Journal

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

(2017) Xiaowei Zhang et al.   Journal of the American Heart Association

Effective method for drug injection into subcutaneous tissue

(2017) Hyejeong Kim et al.   Scientific Reports

Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: A pilot study

(2016) Melissa Leung et al.   Diabetes & Vascular Disease Research

Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes

(2016) Ivan Tkáč et al.   DIABETES CARE

Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic review

(2016) Helene Bihan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure

(2016) Daniel F. Arruda-Junior et al.   Frontiers in Physiology

Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats

(2015) Hiromichi Murase et al.   Cardiovascular Diabetology

Cardiovascular disease in Europe — epidemiological update 2015

(2015) Nick Townsend et al.   EUROPEAN HEART JOURNAL

Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction

(2015) Tharnwimol Inthachai et al.   EXPERIMENTAL PHYSIOLOGY

Potential Role of Dipeptidyl Peptidase IV in the Pathophysiology of Heart Failure

(2015) Thiago Salles et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

(2015) Jennifer B. Green et al.   NEW ENGLAND JOURNAL OF MEDICINE

Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies

(2014) T. Wang et al.   DIABETES OBESITY & METABOLISM

Epidemiology of Heart Failure

(2013) Véronique L. Roger   CIRCULATION RESEARCH

The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin

(2013) Tayebe Pourghaznein et al.   JOURNAL OF CLINICAL NURSING

Morphine Decreases Clopidogrel Concentrations and Effects

(2013) Eva-Luise Hobl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

(2013) William B. White et al.   NEW ENGLAND JOURNAL OF MEDICINE

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

(2013) Benjamin M. Scirica et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus

(2013) Sonal Singh et al.   JAMA Internal Medicine

SDF-1 in myocardial repair

(2012) M S Penn et al.   GENE THERAPY

Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

(2012) Jose Angel Urbano-Moral et al.   HEART

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

(2011) Meimei Yin et al.   Cardiovascular Diabetology

Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes

(2011) M.-M. Zaruba et al.   EUROPEAN HEART JOURNAL

A review of gliptins in 2011

(2011) André J Scheen   EXPERT OPINION ON PHARMACOTHERAPY

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

(2011) Michael Elashoff et al.   GASTROENTEROLOGY

Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure

(2011) S Sundararaman et al.   GENE THERAPY

Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis

(2011) Hans D. Theiss et al.   Stem Cell Research

Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

(2010) Alberto Dominguez-Rodriguez et al.   ATHEROSCLEROSIS

Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline

(2010) A. Taddio et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice

(2010) M. Sauve et al.   DIABETES

Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction

(2009) Marc-Michael Zaruba et al.   Cell Stem Cell

Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials

(2009) M. Monami et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES